Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting-Reference-Cited by-同舟云学术

Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting

Published:2022-10-24 Issue:3 Volume:19 Page:294-307
ISSN:1550-2724
Container-title:LEUKOS
language:en
Short-container-title:LEUKOS

Author:

Feigl Beatrix¹²³^ORCID,Carter Drew D.¹⁴,Zele Andrew J.¹⁴^ORCID

Affiliation:

1. Melanopsin Photoreception and Visual Science Laboratories, Centre for Vision and Eye Research, Queensland University of Technology (QUT), Brisbane, Australia

2. School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Australia

3. Queensland Eye Institute, Brisbane, Australia

4. School of Optometry and Vision Science, Queensland University of Technology (QUT), Brisbane, Australia

Funder

Australian Research Council

Michael J. Fox Foundation for Parkinson’s Research

Publisher

Informa UK Limited

Subject

Atomic and Molecular Physics, and Optics

Link

https://www.tandfonline.com/doi/pdf/10.1080/15502724.2022.2123816

Reference86 articles.

1. Rhodopsin and Melanopsin Contributions to the Early Redilation Phase of the Post-Illumination Pupil Response (PIPR)

2. Effect of Age and Refractive Error on the Melanopsin Mediated Post-Illumination Pupil Response (PIPR)

3. Supplemental light exposure improves sleep architecture in people with type 2 diabetes

4. Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma

5. Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanopsin-mediated amplification of cone signals in the human visual cortex;Proceedings of the Royal Society B: Biological Sciences;2024-05

2. Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial;eClinicalMedicine;2024-03

3. Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease;Journal of Neurology;2023-11-09

4. Protocol for isolation of melanopsin and rhodopsin in the human eye using silent substitution;STAR Protocols;2023-03

5. Melanopsin Vision;ELEMENTS PERCEPT;2022-12-15